Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2026-01-04 @ 2:29 AM
Study NCT ID:
NCT04735393
Status:
COMPLETED
Last Update Posted:
2025-11-26
First Post:
2021-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
Sponsor:
Aldeyra Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-11
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-25
First Submit QC Date:
None
Study First Post Date:
2021-02-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-10-17
Results First Submit QC Date:
None
Results First Post Date:
2025-11-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-11-26
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED